Related references
Note: Only part of the references are listed.Role of NF-?B during Mycobacterium tuberculosis Infection
Nicole Poladian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Pathogenicity and virulence of Mycobacterium tuberculosis
Kathryn C. Rahlwes et al.
VIRULENCE (2023)
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
Anna-Polina Shurygina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Clinical manifestations and immune response to tuberculosis
Mary Lilian Carabali-Isajar et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2023)
Vaccines against Tuberculosis: Where Are We Now?
Shruti Srivastava et al.
VACCINES (2023)
Integer time series models for tuberculosis in Africa
Oluwadare O. Ojo et al.
SCIENTIFIC REPORTS (2023)
Interleukin-12 as an in situ cancer vaccine component: a review
Emily M. Cheng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis
Sujhey Hernandez-Bazan et al.
HUMAN GENE THERAPY (2022)
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis
Elodie Belnoue et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis
Reena Bharti et al.
TUBERCULOSIS (2022)
mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
Anna Rosa Garbuglia et al.
VIRUSES-BASEL (2022)
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
Zhidong Hu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Immunotherapeutic effect of adenovirus encoding antimicrobial peptides in experimental pulmonary tuberculosis
Octavio Ramos-Espinosa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
Adenovirus Core Proteins: Structure and Function
Shermila Kulanayake et al.
VIRUSES-BASEL (2021)
Extrapulmonary tuberculosis
Surendra K. Sharma et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
A 2-Dose AERAS-402 Regimen Boosts CD8+ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
Dhanasekaran Sivakumaran et al.
FRONTIERS IN IMMUNOLOGY (2021)
Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis
Rafael G. Ferreira et al.
PROCESSES (2021)
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost in healthy UK adults
Morven Wilkie et al.
VACCINE (2020)
Immune Responses to Viral Gene Therapy Vectors
Jamie L. Shirley et al.
MOLECULAR THERAPY (2020)
Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis
Reena Bharti et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29
Nicholas B. Carrigy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Immune Response to Mycobacterium tuberculosis: A Narrative Review
Maurizio de Martino et al.
FRONTIERS IN PEDIATRICS (2019)
Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings
Sara Yukie Rodriguez-Takeuchi et al.
RADIOGRAPHICS (2019)
Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters
Daniel A. Montes-Galindo et al.
ARCHIVES OF VIROLOGY (2019)
Adenoviruses across the animal kingdom: a walk in the zoo
Balazs Harrach et al.
FEBS LETTERS (2019)
Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis
Dulce Adriana Mata-Espinosa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)
Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
Frida Arrey et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
Scott G. Hansen et al.
NATURE MEDICINE (2018)
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
H. M. Adnan Hameed et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
The use of immunotherapy for the treatment of tuberculosis
Octavio Ramos-Espinosa et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2018)
Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure
Ke-yang Liu et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2016)
Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis
Alejandro Francisco-Cruz et al.
TUBERCULOSIS (2016)
Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1
Rebecca J. Nusbaum et al.
SCIENTIFIC REPORTS (2016)
Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis
Octavio Ramos-Espinosa et al.
PATHOGENS AND DISEASE (2016)
Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
E. Stylianou et al.
VACCINE (2015)
Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls
Mohan Babu Appaiahgari et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Antimicrobial Peptides: Promising Compounds Against Pathogenic Microorganisms
J. Cruz et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial
Iman Satti et al.
LANCET INFECTIOUS DISEASES (2014)
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses
Benjamin M. N. Kagina et al.
VACCINE (2014)
The Immune Response in Tuberculosis
Anne O'Garra et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Immunotherapeutic effects of recombinant adenovirus encoding granulocytemacrophage colony-stimulating factor in experimental pulmonary tuberculosis
A. Francisco-Cruz et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007
L. F. Anderson et al.
EUROSURVEILLANCE (2013)
Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers
Cesar Enrique Rivas-Santiago et al.
IMMUNOTHERAPY (2013)
A Humanized Mouse Model of Tuberculosis
Veronica E. Calderon et al.
PLOS ONE (2013)
A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
Fiona Smaill et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Goats Primed with Mycobacterium bovis BCG and Boosted with a Recombinant Adenovirus Expressing Ag85A Show Enhanced Protection against Tuberculosis
Bernat Perez de Val et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
The Pathology of Mycobacterium tuberculosis Infection
K. Sakamoto
VETERINARY PATHOLOGY (2012)
Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis
J. Castaneda-Delgado et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Factors that deregulate the protective immune response in tuberculosis
Rogelio Hernandez-Pando et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model
Brenda Marquina-Castillo et al.
IMMUNOLOGY (2009)
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
Zhou Xing et al.
PLOS ONE (2009)
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice
Pin-Yu Perera et al.
VACCINE (2009)
Osteopontin: Role in immune regulation and stress responses
Kathryn X. Wang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine
Elizabeth K. Roediger et al.
MOLECULAR THERAPY (2008)
Therapeutic effect of recombinant adenovirus encoding interferon-γ in a murine model of progressive pulmonary tuberculosis
Dulce A. Mata-Espinosa et al.
MOLECULAR THERAPY (2008)
Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide
Florian Kreppel et al.
MOLECULAR THERAPY (2008)
The potential role of lung epithelial cells and β-defensins in experimental latent tuberculosis
B. Rivas-Santiago et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
β-defensin gene expression during the course of experimental tuberculosis infection
Bruno Rivas-Santiago et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs
KI Happel et al.
INFECTION AND IMMUNITY (2005)
Mechanisms of mucosal and parenteral tuberculosis vaccinations: Adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within airway limen
M Santosuosso et al.
JOURNAL OF IMMUNOLOGY (2005)
Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes
GS García-Romo et al.
IMMUNOLOGY (2004)
Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis
AK Arriaga et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The promise and potential hazards of adenovirus gene therapy
LS Young et al.
GUT (2001)
Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards Type-2 in experimental pulmonary tuberculosis in Balb/c mice
R Hernandez-Pando et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2000)
Share Paper
